Uncategorized

RA Capital banks $75M for a biotech SPAC

Published

on

Research Alliance III follows a few months after Cormorant Asset Management priced a $150 million IPO for its own blank-check entity.

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version